Rapid Dose Therapeutics Corp. (CSE:DOSE)

Rapid Dose Therapeutics Statistics

Total Valuation

CSE:DOSE has a market cap or net worth of CAD 19.60 million. The enterprise value is 25.26 million.

Market Cap	19.60M
Enterprise Value	25.26M

Important Dates

The last earnings date was Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	n/a

Share Statistics

CSE:DOSE has 135.18 million shares outstanding. The number of shares has increased by 7.98% in one year.

Current Share Class	135.18M
Shares Outstanding	135.18M
Shares Change (YoY)	+7.98%
Shares Change (QoQ)	+59.51%
Owned by Insiders (%)	15.13%
Owned by Institutions (%)	n/a
Float	114.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.05
PB Ratio	-2.95
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.78
EV / Sales	9.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.98

Financial Position

The company has a current ratio of 0.08

Current Ratio	0.08
Quick Ratio	0.04
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-6.62
Interest Coverage	-2.38

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-70.49%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	69.24%
Weighted Average Cost of Capital (WACC)	3.47%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.02
Inventory Turnover	5.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.50% in the last 52 weeks. The beta is -0.90, so CSE:DOSE's price volatility has been lower than the market average.

Beta (5Y)	-0.90
52-Week Price Change	-27.50%
50-Day Moving Average	0.15
200-Day Moving Average	0.18
Relative Strength Index (RSI)	50.39
Average Volume (20 Days)	48,307

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:DOSE had revenue of CAD 2.78 million and -4.37 million in losses. Loss per share was -0.03.

Revenue	2.78M
Gross Profit	1.40M
Operating Income	-3.08M
Pretax Income	-4.37M
Net Income	-4.37M
EBITDA	-2.65M
EBIT	-3.08M
Loss Per Share	-0.03

Balance Sheet

The company has 109,163 in cash and 5.77 million in debt, with a net cash position of -5.66 million or -0.04 per share.

Cash & Cash Equivalents	109,163
Total Debt	5.77M
Net Cash	-5.66M
Net Cash Per Share	-0.04
Equity (Book Value)	-6.65M
Book Value Per Share	-0.05
Working Capital	-7.57M

Cash Flow

In the last 12 months, operating cash flow was -864,806 and capital expenditures -6,639, giving a free cash flow of -871,445.

Operating Cash Flow	-864,806
Capital Expenditures	-6,639
Free Cash Flow	-871,445
FCF Per Share	-0.01

Margins

Gross margin is 50.44%, with operating and profit margins of -110.68% and -157.17%.

Gross Margin	50.44%
Operating Margin	-110.68%
Pretax Margin	-157.17%
Profit Margin	-157.17%
EBITDA Margin	-95.17%
EBIT Margin	-110.68%
FCF Margin	n/a

Dividends & Yields

CSE:DOSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.98%
Shareholder Yield	-7.98%
Earnings Yield	-22.30%
FCF Yield	-4.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CSE:DOSE has an Altman Z-Score of -20.37 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-20.37
Piotroski F-Score	2